Does Dr. SUHAIR ABDEL-JALIL have financial conflicts of interest?

Dr. SUHAIR ABDEL-JALIL (MD) has received a total of $327 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $327 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SUHAIR ABDEL-JALIL?

According to CMS Open Payments data, Dr. SUHAIR ABDEL-JALIL received funding from ASTRAZENECA PHARMACEUTICALS ($124), NOVO NORDISK ($98), and ABBVIE ($77).

Does Dr. SUHAIR ABDEL-JALIL receive research grants or speaking fees?

Dr. SUHAIR ABDEL-JALIL has received $327 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SUHAIR ABDEL-JALIL

MDReal-Time Hydrated

Specialty: Internal Medicine, Rheumatology

Practice Location: EVANSTON, IL 60202

NPI Number: 1174572929

LIFETIME INDUSTRY VALUE

$327

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABDEL-JALIL is a verified Internal Medicine, Rheumatology practitioner based in EVANSTON, IL.

Between 2021 and 2024, Dr. ABDEL-JALIL had an overall industry promotional and research financial footprint of $327 as recorded in the federal CMS Open Payments database.

$327 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABDEL-JALIL's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $124 (representing 38% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$124

38%

NOVO NORDISK

Rank 2

$98

29.8%

ABBVIE

Rank 3

$77

23.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.